131 related articles for article (PubMed ID: 38452721)
1. Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio).
Embaby A; Heinhuis KM; IJzerman NS; Koenen AM; van der Kleij S; Hofland I; van Boven H; Sanders J; van der Graaf WTA; Haas RL; Huitema ADR; van Houdt WJ; Steeghs N
Eur J Cancer; 2024 May; 202():113974. PubMed ID: 38452721
[TBL] [Abstract][Full Text] [Related]
2. PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study.
Heinhuis KM; IJzerman NS; Koenen AM; van der Graaf WTA; Haas RL; Beijnen JH; Huitema ADR; van Houdt WJ; Steeghs N
BMJ Open; 2020 Sep; 10(9):e039449. PubMed ID: 32912994
[TBL] [Abstract][Full Text] [Related]
3. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.
Pasquier E; André N; Street J; Chougule A; Rekhi B; Ghosh J; Philip DSJ; Meurer M; MacKenzie KL; Kavallaris M; Banavali SD
EBioMedicine; 2016 Apr; 6():87-95. PubMed ID: 27211551
[TBL] [Abstract][Full Text] [Related]
4. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
Stiles JM; Amaya C; Rains S; Diaz D; Pham R; Battiste J; Modiano JF; Kokta V; Boucheron LE; Mitchell DC; Bryan BA
PLoS One; 2013; 8(3):e60021. PubMed ID: 23555867
[TBL] [Abstract][Full Text] [Related]
5. Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).
Wagner MJ; Othus M; Patel SP; Ryan C; Sangal A; Powers B; Budd GT; Victor AI; Hsueh CT; Chugh R; Nair S; Leu KM; Agulnik M; Sharon E; Mayerson E; Plets M; Blanke C; Streicher H; Chae YK; Kurzrock R
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34380663
[TBL] [Abstract][Full Text] [Related]
6. Beta-blockers for preventing aortic dissection in Marfan syndrome.
Koo HK; Lawrence KA; Musini VM
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011103. PubMed ID: 29110304
[TBL] [Abstract][Full Text] [Related]
7. Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.
Chow W; Amaya CN; Rains S; Chow M; Dickerson EB; Bryan BA
JAMA Dermatol; 2015 Nov; 151(11):1226-9. PubMed ID: 26375166
[TBL] [Abstract][Full Text] [Related]
8. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
[TBL] [Abstract][Full Text] [Related]
9. A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).
Oashi K; Shibata T; Namikawa K; Takahashi A; Yokota K; Nakano E; Teramoto Y; Tsutsumida A; Maeda T; Yamazaki N;
BMC Cancer; 2020 Jul; 20(1):652. PubMed ID: 32660439
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.
Kaempfen S; Neumann RP; Jost K; Schulzke SM
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011893. PubMed ID: 29499081
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Quantitative Parameters of
Kato A; Nakamoto Y; Ishimori T; Saga T; Togashi K
AJR Am J Roentgenol; 2020 Mar; 214(3):649-657. PubMed ID: 31939696
[No Abstract] [Full Text] [Related]
12. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
Kang F; Ma W; Ma X; Shao Y; Yang W; Chen X; Li L; Wang J
J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
[TBL] [Abstract][Full Text] [Related]
13. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.
Ravi V; Subramaniam A; Zheng J; Amini B; Trinh VA; Joseph J; Mennel RG; Bishop AJ; Sturgis EM; Goepfert RP; Yalamanchili S; Botello G; Stephen B; Piha-Paul SA; Patel AB; Lazar AJ; Conley AP; Benjamin RS; Patel SR; Futreal PA; Somaiah N; Naing A
Cancer; 2022 Sep; 128(18):3383-3391. PubMed ID: 35792683
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Primary bilateral angiosarcoma of the breast treated with neoadjuvant chemotherapy combined with propranolol.
Luczynska E; Rudnicki W; Kargol J; Szpor J; Hodorowicz-Zaniewska D; Wysocki PJ; Gorski M; Popiela TJ
Breast J; 2021 Oct; 27(10):781-786. PubMed ID: 34263505
[TBL] [Abstract][Full Text] [Related]
16. Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment.
Galván DC; Ayyappan AP; Bryan BA
Oncoscience; 2018 Sep; 5(9-10):264-268. PubMed ID: 30460329
[TBL] [Abstract][Full Text] [Related]
17. Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.
Gandhi S; Pandey MR; Attwood K; Ji W; Witkiewicz AK; Knudsen ES; Allen C; Tario JD; Wallace PK; Cedeno CD; Levis M; Stack S; Funchain P; Drabick JJ; Bucsek MJ; Puzanov I; Mohammadpour H; Repasky EA; Ernstoff MS
Clin Cancer Res; 2021 Jan; 27(1):87-95. PubMed ID: 33127652
[TBL] [Abstract][Full Text] [Related]
18. The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study.
Porcelli L; Garofoli M; Di Fonte R; Fucci L; Volpicella M; Strippoli S; Guida M; Azzariti A
Sci Rep; 2020 Jun; 10(1):10465. PubMed ID: 32591592
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and adverse events of anthracycline and propranolol combination in five dogs with stage 3 hemangiosarcoma.
Terauchi M; Fujii Y; Goto S; Iwasaki R; Yoshikawa R; Mori T
Open Vet J; 2023 Jun; 13(6):801-806. PubMed ID: 37545711
[TBL] [Abstract][Full Text] [Related]
20. Prognostic usefulness of clinical features and pretreatment
Chen D; Tang M; Lv S; Wang H; Du W; Zhao X; Lin L; Zhu Y; Wang G; Zhu H; Zhao K
Quant Imaging Med Surg; 2022 May; 12(5):2792-2804. PubMed ID: 35502366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
